EZHIP and ependymoma: This initial hypothesis was further supported by later in-depth sequencing efforts on larger series of PFA ependymomas in which rare but recurrent mutations were identified in epigenetic proteins like enhancer of zeste inhibitory protein (EZHIP) and Histone H3 (H3) [56].